Neuroregulation of growth hormone secretion in man

Developmental Brain Dysfunction

Volumn 9, Issue 2-3, 1996, Pages 93-99

  Arvat, E ^a   Bellone, J ^a   Procopio, M ^a   Grottoli, S ^a   Meccario, M ^a   Camanni, F ^a   Ghigo, E ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Acetylcholine; Arginine; Catecholamines; Galanin; GH; GHRH; Growth hormone releasing peptides; Somatostatin

Indexed keywords

ACETYLCHOLINE; ARGININE; CATECHOLAMINE; GALANIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOSTATIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFANT; NEWBORN; POSTNATAL DEVELOPMENT;

EID: 0030035893     PISSN: 10195815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ghigo E: Neurotransmitter control of growth hormone secretion; in de la Cruz F (ed): Growth Hormone and Somatic Growth. Amsterdam, Excerpta Medica, 1992, pp 103-136.
2. Casanueva FF: Physiology of growth hormone secretion and action; in Melmed S (ed): Endocrinology and Metabolism Clinics of North America. Philadelphia, Saunders, 1992, vol 21, pp 483-517.
3. Muller EE, Cocchi D, Locatelli V (eds): Growth Hormone and Somatomedins during Lifespan. Berlin, Springer, 1994.
4. Muller EE, Nisticò G: Neurotransmitter regulation of the anterior pituitary; in Muller EE, Nisticò G (eds): Brain Messengers and the Pituitary. Chicago, Academic Press, 1989, pp 404-537.
5. Ghigo E, Camanni F: Cholinergic nervous system and GH secretion. Cur Med Lit Growth Factors 1990;5:35-39.
6. Arvat E, Cappa M, Casanueva FF, Dieguez D, Ghigo E, Nicolosi M, Valcavi R, Zini M: Pyridostigmine potentiates growth hormone (GH)releasing hormone-induced GH release in both men and women. J Clin Endocrinol Metab 1993;76:374-377.
7. Magnan E, Cataldi M, Guillaume V, Mazzocchi L, Dutour A, Contedevelox B, Giraud P, Oliver C: Neostigmine stimulates growth hormone-releas- ing hormone into hypophysial portal blood of conscious sheep. J Clin Endocrinol Metab 1983;132:1247-1451.
8. Ghigo E: Neural control of GH secretion in aged humans; in Muller EE, Cocchi D, Locatelli V (eds): Growth Hormone and Somatomedins during Lifespan. Berlin, Springer, 1994, pp 275-287.
9. Ghigo E, Nicolosi M, Arvat E, Marcone A, Danelon F, Mucci M, Franceschi M, Smirne S, Camanni F: Growth hormone secretion in Alzheimer's disease: Studies with growth hormonereleasing hormone alone and combined with pyridostigmine or arginine. Dementia 1993;4:315-320.
10. Ghigo E, Arvat E, Bellone J, Ramunni J, Camanni F: Neurotransmitter control of growth hormone secretion in humans. J Paediatr Endocrinol 1993; 6;263-266.
11. Ghigo E, Arvat E, Gianotti L, Ramunni J, Maccario M, Camanni F: Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans. Clin Endocrinol 1994;40:799-802.
12. Ghigo E, Valetto MR, Gaggero L, Visca A, Valente F, Bellone J, Castello D, Camanni F: Therapeutical doses of salbutamol inhibit the somatotropic responsiveness to growth hormonereleasing hormone in asthmatic children. J Endocrinol Invest 1993;16:271-275.
13. Ghigo E, Goffi S, Nicolosi M, Arvat E, Valente F, Mazza E, Ghigo MC, Camanni F: Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J Clin Endocrinol Metab 1990;71:874-876.
14. Vrontakis ME, Torsello A, Friesen HG: Galanin. J Endocrinol Invest 1991;14:785-794.
15. Giustina A, Bussi AR, Conti C, Doga M, Legati F, Macca C, Zuccato F, Wehrenberg WB: Comparative effect of galanin and pyridostigmine on the growth hormone response to growth hormonereleasing hormone in normal aged subjects. Horm Res 1992:37:165-170.
16. Bowers CY: GH releasing peptides. Structure and kinetics. J Pediatr Endocrinol 1993;6:21-31.
17. Bowers CY, Veeraragavan K, Sethumadhavan K: Atypical growth hormone releasing peptides; in Bereu BB, Walker RF (eds): Growth Hormone II Basic and Clinical Aspects. Berlin, Springer, 1993, pp 203-222.
18. Locatelli V, Battisti C, Grilli R, Luoni M, Torsello A, Deghenghi R, Muller EE: Hexarelin, a new growth hormone releasing peptide: Characterization of its GH-releasing activity in the infant rat. (abstract). 76th Annu Meet Endocr Soc, June 15-18, 1984, p 365.
19. Arvat E, Gianotti L, Di Vito L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E: Neuroendocrinological modulation of the growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 1995;61:51-56.
20. Maccario M, Arvat E, Procopio M, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, Ghigo E: Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metabolism 1995;44:234-238.
21. Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F: Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man. J Clin Endocrinol Metab 1994;78:693-698.
22. Bowers CY, Aster DK, Frenz JM: The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab 1992;74:292-298.
23. Ghigo E, Arvat E, Rizzi G, Goffi S, Grottoli S, Mucci M, Boghen MF, Camanni F: The GH-releasing activity of GHRF-6 is maintained after short term oral pretreatment with the hexapeptide in normal ageing. Eur J Endocrinol 1994;131:1-5.